title: Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model.
authors.forename: Johannes
authors.initials: J
authors.lastname: Winning
authors.forename: Ralf A
authors.initials: RA
authors.lastname: Claus
authors.forename: Mathias W
authors.initials: MW
authors.lastname: Pletz
authors.forename: Michael
authors.initials: M
authors.lastname: Bauer
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Lösche
mesh_terms: D000818:Animals; D000077144:Clopidogrel; D006801:Humans; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy*; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000633:toxicity*; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D051381:Rats; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015850:Interleukin-6; D008070:Lipopolysaccharides; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D014409:Tumor Necrosis Factor-alpha; D000077144:Clopidogrel; D013988:Ticlopidine